CTRI/2022/05/042724尚未招募未知
PRIMARY OBJECTIVE To evaluate the in-vivo efficacy and safety of a skin care formulation in terms of reduction in acne & acne PIH, improvement in skin texture (i.e., softness & smoothness), reduction in pore size, reduction in sebum content, improvement in skin brightenesss on healthy male & female subjects. SECONDARY OBJECTIVE To evaluate the in-vivo efficacy of a skin care formulation in terms of balancing skin pH and improvement in skin plumpness on healthy male & female subjects.
Kama Ayurveda Pvt Ltd0 个研究点目标入组 0 人开始时间: 待定最近更新:
试验速览
- 阶段
- 未知
- 状态
- 尚未招募
- 发起方
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
入选标准
- •1Indian male and female subjects
- •2Healthy subjects (no infectious and evolutive pathology which could make the subject vulnerable and stop the study, no pathology which could interfere with the study, no symptom in the process of an exploratory checkup)
- •3Skin is healthy on the studied anatomic unit (free of eczema, wounds, inflammatory scar) Specific criteria
- •4Having oily & mixed oily skin (having acne prone skin) and combination skin type with acne lesions, blackhead, whiteheads & visible pores
排除标准
- •1For Females: Being pregnant or breastfeeding or having stopped to breastfeed in the past three months
- •2Having refused to give her/his assent by signing the consent form
- •3Taking part in another study liable to interfere with this study
- •4Being insulin-dependent diabetic or non insulin-dependent diabetic with a recent therapy (less than 6 months)
- •5Being asthmatic.
- •6Having a diagnosed or highly probable allergy to one or several compounds of the cosmetic products or food products or to latex
- •7Following a chronic medicinal treatment comprising any of the following products: aspirin based products, anti-inflammatories, anti-histamines, corticotherapy, taken by general or local routes (the only medication permitted is paracetamol).
- •8Having cutaneous hypersensitivity.
- •9Having a diagnosed or highly probable allergy to one or several compounds of the cosmetic products.
- •10Having undergone a surgery requiring a general anaesthetic of more than one hour in the past 6 months.
- •11Having changed his/her cosmetic habits in the 14 days preceding the start of the study on the studied anatomic unit.
- •12Having applied a cosmetic product (included make-up) on the studied areas the first day of the study (only face cleaned with water is accepted)
- •13Refusing to follow the restrictions below during the study: For Females: Do not take part in any family planning activities leading to pregnancy and breastfeeding, Do not take part in another study liable to interfere with this study, Do not take medicinal treatment comprising any of the following products: aspirin-based products, anti-inflammatories, anti-histamines, corticotherapy, taken by general or local routes (the only medication permitted is paracetamol), Do not change his/her cosmetic habits apart from the particular conditions mentioned in the protocol, on the studied anatomic unit., During the study: Do not use other cosmetic products than the tested products to the studied areas, Do not use hair oil ,The day of the measurements : No other cosmetic products must be used (only face cleaned with water is accepted)
- •14In the 6 previous months ,Having started, changed or stopped a hormonal treatment (hormonal contraception, cyproterone acetate â?¦), Having taken an oral retinoid-based treatment
- •15In the previous month, Having undergone a physical (phototherapy, laser ..) or chemical (peeling) treatment for acne, Having had a local benzoyl-peroxide-based treatment or a local retinoid-based treatment,Having had an oral treatment with a base of cimetidine, zinc (gluconate of zinc) or spironolactone
- •16In the 2 previous weeks, Having applied cosmetic products with anti-seborrheic aims or cosmetics for oily skin, Having had oral or local antibiotic treatment for acne, Having had beauty treatment (e.g. skin cleansing, exfoliation, scrub, mask â?¦), Having a suntanned skin on the studied areas which could interfere with the evaluations of the study
- •17Refusing to follow the restrictions below during the study: Do not apply cosmetic products with anti-seborrheic aims or cosmetics for oily skin, Do not have beauty treatment (e.g. skin cleansing, exfoliation, scrub, mask â?¦), Do not start, change or stop a hormonal treatment (hormonal contraception, cyproterone acetate â?¦), Do not start a local or general treatment acting on seborrhoea , Do not expose himself/herself to the sun, S
研究者
相似试验
尚未招募
不适用
Evaluation of safety and efficacy of skin care formulatioCTRI/2022/08/044838DPKA Universal Consumer Ventures Private Limited
招募中
不适用
Safety and efficacy of skin care formulatioCTRI/2022/01/039184Kama Ayurveda Pvt Ltd
尚未招募
不适用
Safety and efficacy assessment of Product on skiCTRI/2022/12/047808Kama Ayurveda Pvt Ltd
已完成
不适用
Safety and efficacy assessment of Product on skiCTRI/2022/03/040715Kama Ayurveda Pvt Ltd33
已完成
不适用
Safety and efficacy assessment of Product on skiCTRI/2023/02/049828Kama Ayurveda Pvt Ltd36